Search Results 1-10 of 26643 for Two-phase

1. A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic

   A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma - Mayo Clinic Overview Study type Interventional Study phase II/III Study IDs Study type Interventional Describes the nature of a clinical study...

2. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Cl...

   A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastin...

3. A Phase II Study of ABC294640 as Second-Line Monotherapy in Patients With Advanced Hepatocellular Carcinoma - Mayo Clinic

   A Phase II Study of ABC294640 as Second-Line Monotherapy in Patients With Advanced Hepatocellular Carcinoma - Mayo Clinic Overview Study type Interventional Study phase II Study IDs Study type Interv...

4. A Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects with Primary Biliary Cirrhosis - Mayo Clinic

   A Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects with Primary Biliary Cirrhosis - Mayo Clinic Overview Study type Interventional Study phase II Study IDs Study type Interventional Describes the na...

5. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases.

6. Ketamine: Exploring continuation-phase treatment for depression - Mayo Clinic

   But even when we give multiple infusions over, say, a two-week period, a lot of patients will relapse in about 18 days," says William V.

7. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases.

8. A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - Mayo Clinic

   Study IDs Site IRB Jacksonville, Florida: 13-002454 Rochester, Minnesota: 13-002454 Scottsdale/Phoenix, Arizona: 13-002454 NCT ID: NCT02037529 Sponsor Protocol Number: RU011201I About this study This is a two arm Phase...

9. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic Overview Study type Interventional Study phase...

10. Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma - Mayo Clinic

    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma - Mayo Clinic Overview Study type Interventional Study phase III Study ...